| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cogent Biosciences, Inc. | Director | Stock Option (Right to Buy) | 44.7K | 04 Jun 2025 | Direct | ||
| Viridian Therapeutics, Inc.\DE | Director | Stock Option (Right to Buy) | 21K | 26 Jun 2024 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| COGT | Cogent Biosciences, Inc. | 04 Jun 2025 | 1 | $0 | 4 | Director | 05 Jun 2025, 16:19 |
| VRDN | Viridian Therapeutics, Inc.\DE | 26 Jun 2024 | 1 | $0 | 4 | Director | 28 Jun 2024, 16:05 |
| COGT | Cogent Biosciences, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 13 Jun 2024, 19:11 |
| VRDN | Viridian Therapeutics, Inc.\DE | 14 Jun 2023 | 1 | $0 | 4 | Director | 16 Jun 2023, 20:00 |
| COGT | Cogent Biosciences, Inc. | 07 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 16:37 |
| VRDN | Viridian Therapeutics, Inc.\DE | 08 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 07:30 |
| COGT | Cogent Biosciences, Inc. | 07 Jun 2022 | 1 | $0 | 4 | Director | 09 Jun 2022, 17:08 |
| VRDN | Viridian Therapeutics, Inc.\DE | 03 Jun 2021 | 1 | $0 | 4 | Director | 16 Jun 2021, 18:26 |